Preview

Global And China Orphan Drugs Industry 2014 Market Trend, Size, Share, Growth Research Report

Satisfactory Essays
Open Document
Open Document
813 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Global And China Orphan Drugs Industry 2014 Market Trend, Size, Share, Growth Research Report
The report firstly introduced Orphan Drugs basic information included Orphan Drugs definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Orphan Drugs industry policy and plan, Orphan Drugs product specification, manufacturing process, cost structure etc.

Browse Complete Report with TOC : http://www.qyresearchreports.com/report/global-and-china-orphan-drugs-industry-2014-market-research-report.htm

Then statistics Global and China key manufacturers Orphan Drugs capacity production cost price profit production value gross margin etc information, and Global and China Orphan Drugs capacity production market share supply demand shortage import export consumption etc data statistics, and Orphan Drugs 2009-2014 capacity production price cost profit production value gross margin etc information.

To Get Sample Copy of Report Visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=185759&type=E

And also listed Orphan Drugs upstream raw materials and down stream analysis and Orphan Drugs marketing channels industry development trend and proposals. In the end, The report introduced Orphan Drugs new project SWOT analysis Investment feasibility analysis investment return analysis and also give related research conclusions and development trend analysis on China Orphan Drugs industry. In a word, it was a depth research report on China Orphan Drugs industry. And thanks to the support and assistance from Orphan Drugs industry chain related technical experts and marketing engineers during Research Team survey and interviews.

Table of Contents

Chapter One Orphan Drugs Industry Overview
1.1 Orphan Drugs Definition
1.2 Orphan Drugs Classification and Application
1.3 Orphan Drugs Industry Chain Structure
1.4 Orphan Drugs Industry Overview

Chapter Two Orphan Drugs International and China Market Analysis
Continue Reading
View Writing Issues

You May Also Find These Documents Helpful

  • Good Essays

    General Nutrition Center Case Study
    • 1293 Words
    • 6 Pages

    General Nutrition Center Case Study

    The contribution made by the industry towards the GDP of the country is $ 1.2 trillion, which is 8.5% of the GDP (PWC, 2011). Increase in the wholesale prices of drugs during global financial crises has increased the expenditure to $ 10 billion, which increased to $ 300 billion in the year 2009. It has also increased the inflation rate in the country. In addition to this, it also has a negative impact on the Consumer Price Index, which fell to 1.3% in the year 2009 (Wilson, 2009). It is estimated that the retail drug industry would reach US$ 1420 billion in the year 2017 and there would be a compounded annual growth rate of 3.6% in the next 5 years (Reuters, 2012).…

    • 1293 Words
    • 6 Pages
    Good Essays
    Read More
  • Good Essays

    Swot Analysis on Walgreens
    • 277 Words
    • 2 Pages

    Swot Analysis on Walgreens

    prescription drug market share, and prescription sales per store, and first on the list of Global…

    • 277 Words
    • 2 Pages
    Good Essays
    Read More
  • Satisfactory Essays

    Pharmacy and Urgent Intervention Triage
    • 533 Words
    • 3 Pages

    Pharmacy and Urgent Intervention Triage

    Q5 this business model is very risky, the key is to have expertise in identifying the drugs, which were abandoned by the parent companies for any reason. Pharmaceutical companies, after spending millions of dollars in research, don’t typically abandon their product development, unless they are convinced that their product would be a failure, due to variety of reasons. If proper identification can be done, it saves a large chunk of R&D dollars, especially if the drug is in later stages of development.…

    • 533 Words
    • 3 Pages
    Satisfactory Essays
    Read More
  • Satisfactory Essays

    Prescription Drug Industry Pros And Cons
    • 126 Words
    • 1 Page

    Prescription Drug Industry Pros And Cons

    The Prescription drugs industry is one of my national economy important and special industry. It is closely related to people's health and life security, to protect and improve people's health has played a big role. Also, Industry's profit margin is very considerable. On the other hand, Prescription drug is a special kind of products, has a certain sensitivity, for the quality of the products and technology have very strict requirements. Because it is a direct effects on the human body, is closely related to people's health. The particularity of the industry is that ordinary consumers for the quality of the product and generally difficult to recognize and grasp the nature, generally trusted certification authority. Thus, From my perspective,…

    • 126 Words
    • 1 Page
    Satisfactory Essays
    Read More
  • Powerful Essays

    IA1
    • 1931 Words
    • 6 Pages

    IA1

    Quelch, J. Rodriquez, M. (2013). GlaxoSmithKline in China (A). Harvard Business School. Retrieved from https://cb.hbsp.harvard.edu/cbmp/content/34297188.…

    • 1931 Words
    • 6 Pages
    Powerful Essays
    Read More
  • Good Essays

    Nucleon: The Pharmaceutical Industry
    • 1056 Words
    • 5 Pages

    Nucleon: The Pharmaceutical Industry

    The Pharmaceutical industry has several high entry barriers as shown in figure 1. Economies of scale, product differentiation, government policy and capital requirements and financial services are few barriers for new entrant. Level of threat from rivalry is also high in this industry. Industry has presence of large number of small firms of a similar size. They are in direct competition with one another,…

    • 1056 Words
    • 5 Pages
    Good Essays
    Read More
  • Good Essays

    Pharmaceutical Pricing Strategy
    • 743 Words
    • 3 Pages

    Pharmaceutical Pricing Strategy

    Pharmaceuticals. Southern Economic Journal, 59(2), 165. Retrieved October 27, 2009, from ABI/INFORM Global. (Document ID: 801714). http://proquest.umi.com.ezproxy2.apus.edu/pqdweb?index=10&did=801714&SrchMode=1&sid=3&Fmt=6&VInst=PROD&VType=PQD&RQT=309&VName=PQD&TS=1256670172&clientId=62546…

    • 743 Words
    • 3 Pages
    Good Essays
    Read More
  • Powerful Essays

    Merck Business Analysis
    • 1943 Words
    • 8 Pages

    Merck Business Analysis

    The global pharmaceutical market is likely to undergo a wide variety of changes with new competition arising in India, China, Malaysia, South Korea, and Indonesia. This new competition has a growing economy and has made a difference between the product cost and disposable income of consumers. According to NASDAQ (2011),“ Global pharmaceutical market sales are expected to grow at a 4-7% through the year 2013 largely being driven by the growing access to health care in emerging economic regions” (para. 2-5). Short-term growth within this area is stimulated by the United States market, as it continues to be the largest pharmaceutical market in the world. A focal point on research and development in special drugs and generic drugs will remain a strong means to meet 2011 goals of earning $315 billion dollar in sales within the United States.…

    • 1943 Words
    • 8 Pages
    Powerful Essays
    Read More
  • Good Essays

    Discuss Issues Associated with Pharmaceutical Transnational Corporations Regarding Research, Production and Distribution of Drugs.
    • 381 Words
    • 2 Pages

    Discuss Issues Associated with Pharmaceutical Transnational Corporations Regarding Research, Production and Distribution of Drugs.

    An issue with the distribution of drugs is that it is more profitable for drug companies to sell the drugs in MEDC’s than LEDC’s. An example of this would be GlaxoSmithKline, as they mainly sell their products in MEDC’s, but in many cases, the countries with…

    • 381 Words
    • 2 Pages
    Good Essays
    Read More
  • Good Essays

    World Drug Report 2012
    • 7453 Words
    • 30 Pages

    World Drug Report 2012

    2012 WORLD DRUG REPORT UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna World Drug Report 2012 UNITED NATIONS New York, 2012 © United Nations, June 2012. All rights reserved worldwide. ISBN: 978-92-1-148267-6 e-ISBN: 978-92-1-055653-8 United Nations publication, Sales No. E.12.XI.1 This publication may be reproduced in whole or in part and in any form for educational or non-profit purposes without special permission from the copyright holder, provided acknowledgement of the source is made.…

    • 7453 Words
    • 30 Pages
    Good Essays
    Read More
  • Powerful Essays

    Merck River Blindness
    • 1355 Words
    • 6 Pages

    Merck River Blindness

    This is the flip side of the “orphan” drug dilemma (Nelson, & Trevino, 2011). Merck and Co.’s values was, “We try never to forget that medicine is for people. It is not for the profits. The profits follow, and if we have remembered that, they have never failed to appear” (Nelson, & Trevino, 2011). The statement is their…

    • 1355 Words
    • 6 Pages
    Powerful Essays
    Read More
  • Powerful Essays

    Public Disclosure Research Paper
    • 20224 Words
    • 81 Pages

    Public Disclosure Research Paper

    the market, followed by 36.4 percent for imports and 17.6 percent for joint venture products…

    • 20224 Words
    • 81 Pages
    Powerful Essays
    Read More
  • Good Essays

    Genzyme Case Study
    • 745 Words
    • 3 Pages

    Genzyme Case Study

    1. How does Genzyme’s focus on orphan drugs affect the degree of competition it faces? How does it affect the bargaining power of customers?…

    • 745 Words
    • 3 Pages
    Good Essays
    Read More
  • Satisfactory Essays

    Eli Lily Case Study
    • 489 Words
    • 2 Pages

    Eli Lily Case Study

    It was a right strategy for Eli Lilly that started a joint venture with Ranbaxy to enter the Indian market. First of all, Ranbaxy was the second largest pharmaceutical company that manufactures bulk drugs and generic drugs in India, with a domestic market share of 15 per cent. It had established broad distribution network, and it was the second largest exporter of all products in India. Ranbaxy’s capital costs were 50 per cent to 75 per cent lower than those of comparable U.S. plants. Second, the timing was perfect for Eli Lilly to enter the Indian market. During 1970s, the Patents Act 1970 and the Drug Price Control Order (DPCO) was issued. And India was opening its drug market. Third, there was possibility to conduct cheap clinical trials in India.…

    • 489 Words
    • 2 Pages
    Satisfactory Essays
    Read More
  • Better Essays

    Psychology, Theology, and Spirituality
    • 1353 Words
    • 5 Pages

    Psychology, Theology, and Spirituality

    McMinn, M. (1996). Psychology, Theology, and Spiritual in Christian Counseling: Wheaton, IL: Tyndale House Publishers.…

    • 1353 Words
    • 5 Pages
    Better Essays
    Read More

Related Topics